Raj Chari

7.0k citations

98 papers · 4.2k indexed · 1 hit paper · h-index 36

Impact in

Business and International Management top 2%
Aging top 2%

Papers in

Cancer Research 19
- Cancer-related molecular mechanisms research 9
Molecular Biology 75
- CRISPR and Genetic Engineering 20
- RNA modifications and cancer 15
- RNA and protein synthesis mechanisms 11
- DNA Repair Mechanisms 10
- Genomics and Chromatin Dynamics 10
- Gene expression and cancer classification 9
- Epigenetics and DNA Methylation 9

Co-authors: George M. Church Wan L. Lam William W. Lockwood Calum MacAulay Prashant Mali Alejandro Chavez Mark Moosburner Stephen Lam
Journals: PLoS ONE (6 papers)Journal of Thoracic Oncology (5 papers)Molecular and Cellular Biology (5 papers)Cancer Research (4 papers)BMC Genomics (4 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Raj Chari

91 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Comparison of Cas9 activators in multiple species 2016 · 381 citations

Peers

Countries citing papers authored by Raj Chari

Since Specialization

Citations

This map shows the geographic impact of Raj Chari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raj Chari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raj Chari more than expected).

Fields of papers citing papers by Raj Chari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raj Chari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raj Chari. The network helps show where Raj Chari may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Raj Chari, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Raj Chari Line = papers co-authored together Raj Chari links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The ubiquitin ligase HUWE1 enhances WNT signaling by antagonizing destruction complex-mediated β-catenin degradation and through a mechanism independent of changes in β-catenin abundance PLoS Genetics ·노리타케 가즈오, Yalan Wu, Praveen Sonkusre, N B Kokuashvili, Raj Chari, Andres M. Lebensohn	2025	1
2	DNAJC9 prevents CENP-A mislocalization and chromosomal instability by maintaining the fidelity of histone supply chains The EMBO Journal ·Ahmad AL-Shroosh, Yu Meng Zhang, Colin M. Hammond, 綾安武, Ivo A. Hendriks, Susan J. Balderson, Lu Chen, Samantha Sevilla, Natasha J. Caplen, Raj Chari, Tatiana Karpova, Katherine McKinnon, Matthew Todd, Vishal N. Kopardé, Ken Cheng, Michael L. Nielsen, Anja Groth, Munira A. Basrai	2024	7
3	Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platform Science Advances ·Liping Yang, 幹中村, Erry T. Adesta, Guojun Yu, Pradip Bajgain, Gareth Hoskins, Daeho So, Steven Seaman, 良二牧角, Ling Lin, Christine N. Evans, سهیر صالح إبراهیم, Raj Chari, Brad St. Croix	2024	1
4	The histone H3/H4 chaperone CHAF1B prevents the mislocalization of CENP-A for chromosomal stability Journal of Cell Science ·Roshan L. Shrestha, Ahmad AL-Shroosh, Mahabir Prasad Bhargava, Nikoo Asadi, Dadan Ramdoni, Susan J. Balderson, Laurent Ozbun, 綾安武, George Moldau, Raj Chari, Tatiana Karpova, Gianluca Pegoraro, Daniel R. Foltz, Natasha J. Caplen, Volodumur Z. Pankevuch	2023	8
5	Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants PLoS Genetics ·Sounak Sahu, Teresa Sullivan, Alexander Y. Mitrophanov, Xiang Chun Xi, Darryl Nousome, Eileen Southon, Jillian Taylor, Aulia Yogi Fachlivan, Christine N. Evans, Thamires Farias Pimenta de Lima, Sandra Burkett, 伊東信行, Raj Chari, Kajal Biswas, Shyam K. Sharan	2023	8
6	Enhancer–promoter interactions can bypass CTCF-mediated boundaries and contribute to phenotypic robustness Nature Genetics ·李元中, 作惠酒井, Zhenyu Zuo, Кустов Денис Валерьевич, Parirokh Awasthi, Raj Chari, Apratim Mitra, J. Kim, Sakthi D. Moorthy, Ryan Dale, Jennifer A. Mitchell, Timothy J. Petros, Pedro P. Rocha	2023	52
7	Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR Genes & Development ·Dali Zong, Hervé Wendpagnagdé Ouedraogo, James A. Cornwell, Jiaonan Yang, Michael J. Kruhlak, Nancy Wong, Raj Chari, Steven D. Cappell, André Nussenzweig	2023	9
8	Active DNA demethylation promotes cell fate specification and the DNA damage response Science ·Dongpeng Wang, Wei Wu, Elsa Callén, Raphael Pavani, 琪冰, Srikanth Kodali, Dali Zong, Nancy Wong, A. Carroccio, William J. Nathan, Gabriel Matos‐Rodrigues, Raj Chari, Michael J. Kruhlak, Ferenc Livák, Michael E. Ward, Keith W. Caldecott, Bruno Di Stefano, André Nussenzweig	2022	69
9	Mitochondrial Matrix Protease ClpP Agonists Inhibit Cancer Stem Cell Function in Breast Cancer Cells by Disrupting Mitochondrial Homeostasis Cancer Research Communications ·Yoshimi Endo Greer, Lídia Hernandez, 大吾相内, 丁玉萍, Donna Voeller, Raj Chari, 晋角田, Thomas S.K. Gilbert, Mai-Lan Ho, Binwu Tang, Markus Hafner, Qingrong Chen, Daoud Meerzaman, Edwin J. Iwanowicz, Christina M. Annunziata, Lee M. Graves, Stanley Lipkowitz	2022	20
10	Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins Cancer Research ·Poonam Tewary, Alan D. Brooks, Ya-Ming Xu, E. M. Kithsiri Wijeratne, Ashley L. Babyak, Timothy Back, Raj Chari, Christine N. Evans, Curtis J. Henrich, Thomas J. Meyer, Elijah F. Edmondson, Maria Teresa P. de Aquino, Thanigaivelan Kanagasabai, Anil Shanker, A. A. Leslie Gunatilaka, Thomas J. Sayers	2021	12
11	A structurally conserved site in AUP1 binds the E2 enzyme UBE2G2 and is essential for ER-associated degradation PLoS Biology ·J L Fischer, Yien Che Tsai, Yu‐He Liang, Михалик Т. А., Jennifer Mariano, Jess Li, Sergey G. Tarasov, Mashuan Bactacion, Francis Puel de Lobel, B. D. Lee, Thamires Farias Pimenta de Lima, Valentin Magidson, Raj Chari, R. Andrew Byrd, Xinhua Ji, Allan M. Weissman	2021	11
12	Activating Mucosal-Associated Invariant T Cells Induces a Broad Antitumor Response Cancer Immunology Research ·Benjamin Ruf, D. M. Dubkov, Simon Wabitsch, Chi Ma, Laurence P. Diggs, Qianfei Zhang, Bernd Heinrich, Varun Subramanyam, Linda L. Cui, Marie Pouzolles, Christine N. Evans, Raj Chari, Shunsuke Sakai, Sangmi Oh, Clifton E. Barry, Daniel L. Barber, Tim F. Greten	2021	39
13	The dystonia gene THAP1 controls DNA double-strand break repair choice Molecular Cell ·Kenta Shinoda, Dali Zong, Elsa Callén, Wei Wu, Lavinia C. Dumitrache, Frida Belinky, Raj Chari, Nancy Wong, Momoko Ishikawa, Andre Stanlie, Trisha Multhaupt‐Buell, Nutan Sharma, Laurie J. Ozelius, Michelle E. Ehrlich, Peter J. McKinnon, André Nussenzweig	2021	17
14	dbGuide: a database of functionally validated guide RNAs for genome editing in human and mouse cells Nucleic Acids Research ·美夢髙野, Christine N. Evans, 幹中村, Thamires Farias Pimenta de Lima, Raj Chari	2020	20
15	sgRNA Scorer 2.0: A Species-Independent Model To Predict CRISPR/Cas9 Activity ACS Synthetic Biology ·Raj Chari, Nan Cher Yeo, Alejandro Chavez, George M. Church	2017	174
16	Cas9 gRNA engineering for genome editing, activation and repression DSpace@MIT (Massachusetts Institute of Technology) ·Alejandro Chavez, Marcelle Tuttle, Raj Chari, Dmitry Ter‐Ovanesyan, Jason Qian, Benjamin W. Pruitt, Joanna Buchthal, George M. Church, Samira Kiani, Richard Hall, Jacob Beal, Suhani Vora, Emma J. K. Kowal, Mo R. Ebrahimkhani, James J. Collins, Ron Weiss	2015	1
17	YEATS4 Is a Novel Oncogene Amplified in Non–Small Cell Lung Cancer That Regulates the p53 Pathway Cancer Research ·Larissa A. Pikor, William W. Lockwood, Kelsie L. Thu, Emily A. Vucic, Raj Chari, Adi F. Gazdar, Stephen Lam, Wan L. Lam	2013	39
18	Integrative Genomics Identified RFC3 As an Amplified Candidate Oncogene in Esophageal Adenocarcinoma Clinical Cancer Research ·William W. Lockwood, Kelsie L. Thu, Lin Lin, Larissa A. Pikor, Raj Chari, Wan L. Lam, David G. Beer	2012	37
19	Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations Blood ·Daniel T. Starczynowski, Ryan D. Morin, Andrew McPherson, Jeff Y. L. Lam, Raj Chari, Joanna Węgrzyn, Florian Kuchenbauer, Martin Hirst, Kaoru Tohyama, R. Keith Humphries, Wan L. Lam, Marco A. Marra, Aly Karsan	2010	94
20	Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells PLoS ONE ·Junichi Soh, Naoki Okumura, William W. Lockwood, Hiromasa Yamamoto, Hisayuki Shigematsu, Wei Zhang, Raj Chari, David S. Shames, Ximing Tang, Calum MacAulay, Marileila Varella‐Garcia, Tõnu Vooder, Ignacio I. Wistuba, Stephen Lam, Rolf A. Brekken, Shinichi Toyooka, John D. Minna, Wan L. Lam, Adi F. Gazdar	2009	179

About Raj Chari

Raj Chari is a scholar working on Cancer Research, Molecular Biology, Structural Biology, Genetics and Oncology, having authored 98 papers that have together received 4.2k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (20 papers), RNA modifications and cancer (15 papers), RNA and protein synthesis mechanisms (11 papers), DNA Repair Mechanisms (10 papers), Genomics and Chromatin Dynamics (10 papers), Cancer-related molecular mechanisms research (9 papers), Gene expression and cancer classification (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Business and International Management (129 citations), Aging (104 citations), Cancer Research (816 citations), Molecular Biology (3.2k citations) and Oncology (603 citations). Raj Chari has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include George M. Church, Wan L. Lam, William W. Lockwood, Calum MacAulay, Prashant Mali, Alejandro Chavez, Mark Moosburner, Stephen Lam, Adi F. Gazdar and Bradley P. Coe. Their work appears in journals such as PLoS ONE, Journal of Thoracic Oncology, Molecular and Cellular Biology, Cancer Research and BMC Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact